Fulgent Genetics Statistics
NASDAQ: FLGTHealth CareMedical SpecialitiesUSD
20.57-0.01 (-0.05%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 20.57 0.00%
Fulgent Genetics by the numbers
Fulgent Genetics has a market capitalization of $566.0 million based on 27.52M shares outstanding. With trailing EPS of $-2.94, Fulgent Genetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.4% above its 50-day average and 3.1% above its 200-day average.
Average daily trading volume is 297.73K shares, or about $6.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FLGT valuation vs. peer median
| Metric | FLGT | Peer median | Difference |
|---|---|---|---|
| Market cap | $565.99M | $270.23M | +109% |
| Avg. volume | 297.73K | 283.46K | +5% |
Peer median across 8 companies: YDES, BDSX, TLSI, XGN, BNR, CSTL, LMRI, KEQU.
Valuation
- Market cap
- $565.99M
- EPS (TTM)
- $-2.94
- Shares outstanding
- 27.52M
Price and trading
- Previous close
- 20.58
- Open
- 20.48
- Day range
- 19.90 – 20.70
- 52-week range
- 13.46 – 31.04
- 52-week change
- -9.10%
- Beta
- —
- Volume
- 293.94K
- Average volume
- 297.73K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 565.99M
- Forward Pe
- -14.91
- Eps
- -2.94
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.04
- Week52 Low
- 13.46
- Avg Volume
- 297.73K
- Shares Outstanding
- 27.52M
- Ma50
- 20.09
- Ma200
- 19.95
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -33.73%
- Pct From52w Low
- 52.82%